A Review of Major Danish Biobanks: Advantages and Possibilities of Health Research in Denmark.

"Disclosure MLH reports grants from AbbVie, Biogen, BMS, Celltrion, Eli Lilly, Janssen Biologics B.V., Lundbeck Foundation, MSD, Pfizer, Roche, Samsung Bioepis, Sandoz, Novartis; also reports payment/honoraria for lectures, presentations or similar. No personal income but paid to institution from Pfizer, Medac, and Sandoz; participation in a Data Safety Monitoring Board or Advisory Board. No personal income but paid to institution from AbbVie, outside the submitted work. MLH also has chaired the steering committee of the Danish Rheumatology Quality Registry (DANBIO, DRQ), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs EuroSpA, which generates real-world evidence of treatment of psoriatic arthritis and axial spondyloarthritis based on secondary data and is partly funded by Novartis. LSS reports The Department Clinical Epidemiology is involved in studies with funding from various companies as research grants to and administered by Aarhus University. None of these studies are related to the current study. The authors report no other conflicts of interest in this work."

"There is no funding to report."